NCT05924113 A Study of Latin Dance for Post- Lung Transplant
| NCT ID | NCT05924113 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Lung Transplant |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2023-06-12 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2023-06-12 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is to see if participating in Latin dance for 12 sessions can improve wellbeing in several areas including balance, fear of movement, anxiety, depression and spirometry.
Eligibility Criteria
Inclusion Criteria: \- Ambulatory with or without assisting devices (not on supplemental oxygen is not exclusionary), who have completed outpatient cardiopulmonary rehab and good pain control. Exclusion Criteria: \- Tracheostomy, Hemodialysis, gastro-jejunal tubes, nasogastric tubes, wound vacs, chest tube, high levels of oxygen supplementation (mask vs nasal canula), recent falls.
Contact & Investigator
Teresa Padro, DNP, APRN
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05924113 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Lung Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05924113 currently recruiting?
Yes, NCT05924113 is actively recruiting participants. Contact the research team at Padro.Teresa@mayo.edu for enrollment information.
Where is the NCT05924113 trial being conducted?
This trial is being conducted at Jacksonville, United States.
Who is sponsoring the NCT05924113 clinical trial?
NCT05924113 is sponsored by Mayo Clinic. The principal investigator is Teresa Padro, DNP, APRN at Mayo Clinic. The trial plans to enroll 52 participants.